Business
Novo Integrated Sciences, Inc. Announces Letter of Intent to Acquire U.S. Based Peripheral Neuropathy Health Care Companies
Novo Integrated Sciences, Inc. Announces Letter of Intent to Acquire U.S. Based Peripheral Neuropathy Health Care Companies.
About this update from Novo Integrated Sciences, Inc.
[{"type":"text","content":"\n\n BELLEVUE, Wash., March 19, 2018 (GLOBE NEWSWIRE) -- Novo Integrated Sciences, Inc. (OTCQB:NVOS) (“Novo Integrated Sciences”, the “Company”), through its wholly-owned U.S. based subsidiary, Novomerica Health Group, Inc., a Nevada corporation, announces a signed Letter of Intent (“LOI”) to acquire Illinois Spine and Disc Institute, Ltd. (“ISDI”) and Progressive Health and Rehabilitation, Ltd. (“Progressive”), both of which are Illinois based medical care corporations devoted to the diagnosis, treatment and rehabilitation of peripheral neuropathy related spine and neck disorder.\n The pending acquisition transaction definitive agreement is contemplated as a share only transaction with a closing date no later than June 1, 2018. As provided for in the LOI, Dr. Jason Y. Hui, the founder and owner of both ISDI and Progressive, is to remain as the primary operator of both ISDI and Progressive under terms and conditions to be defined in both an employee agreement and a management agreement pursuant to the regulations of the Illinois Corporate Practice of Medicine Act.  In addition, upon closing of the acquisition transaction, Dr. Hui is expected to assume the role and responsibilities as Novo Integrated Sciences’ Medical Director overseeing the implementation of all corporate wide diagnosis, treatment, rehabilitative and wellness program best practice protocols. Holding two doctorate degrees with over 350 post-doctorate hours completed, two Board Certifications and as a specialist member on the Medical Advisory Board for the American College of Physical Medicine, Dr. Hui is recognized as a leading authority in musculoskeletal rehabilitation. Dr. Hui has treated over 5,000 patients with various conditions such as headaches, neck and back pain, sciatica, fatigue, sleep problems, digestive problems, weight loss, hormonal imbalances, arthritis, Carpal Tunnel Syndrome and Fibromyalgia.   The Company’s business strategy is centered on building a network of U.S. and Canada based clinics providing both specialized primary care and multi-disciplinary primary healthcare services and products with an emphasis on pain diagnosis, treatment, rehabilitation and management through the integration of technology and medical science. The exchange of treatment strategies,...